Notice of NCATS' Participation in PA-20-135 "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)"

Notice Number: NOT-TR-20-013

Key Dates
Release Date: April 8, 2020

Related Announcements
PA-20-135 - Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)

Issued by
National Center for Advancing Translational Sciences (NCATS)

Purpose

The purpose of this Notice is to inform applicants that the National Center for Advancing Translational Sciences (NCATS) will participate, effective immediately, in PA-20-135 "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)".

The following changes and updates are made to PA-20-135 (shown in italics) to reflect NCATS’ participation in this funding opportunity announcement (FOA).

Part 1. Overview Information

Components of Participating Organizations

National Cancer Institute (NCI)

National Center for Complementary and Integrative Health (NCCIH)

National Human Genome Research Institute (NHGRI)

National Institute of Allergy and Infectious Diseases (NIAID)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute of Environmental Health Sciences (NIEHS)

National Institute of General Medical Sciences (NIGMS)

National Institute of Mental Health (NIMH)

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

National Center for Advancing Translational Sciences (NCATS)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.213, 93.393, 93.394, 93.395, 93.396, 93.399, 93.172, 93.855, 93.865, 93.847, 93.113, 93.142, 93.143, 93.859, 93.307, 93.286, 93.350

Inquiries

Please direct all inquiries to:

For any scientific or research-related questions on this emergency competitive revisions notice please contact the Program Officer listed on the NoA of the most recent parent award.